Werner Rittgen

2.6k citations

38 papers · 2.0k indexed · h-index 24

Impact in

Otorhinolaryngology top 2%
- Head and Neck Cancer Studies
Oncology top 2%
- Cutaneous Melanoma Detection and Management
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Cancer-related Molecular Pathways

Papers in

Otorhinolaryngology 4
- Head and Neck Cancer Studies 4
Oncology 14
- Cutaneous Melanoma Detection and Management 4
- Cancer-related Molecular Pathways 3

Co-authors: Dirk Schadendorf M Volm P. Drings Antje Sucker Selma Ugurel Jürgen C. Becker Lutz Edler Petra Keikavoussi
Journals: International Journal of Cancer (7 papers)Cancer Letters (4 papers)British Journal of Cancer (3 papers)Mathematical Biosciences (2 papers)International Journal of Oncology (2 papers)
Partner nations: Germany United States Sweden

In The Last Decade

Werner Rittgen

38 papers receiving 1.9k citations

Peers

Countries citing papers authored by Werner Rittgen

Since Specialization

Citations

This map shows the geographic impact of Werner Rittgen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Werner Rittgen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Werner Rittgen more than expected).

Fields of papers citing papers by Werner Rittgen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Werner Rittgen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Werner Rittgen. The network helps show where Werner Rittgen may publish in the future.

Co-authors

The 25 scholars most cited alongside Werner Rittgen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Werner Rittgen Line = papers co-authored together Werner Rittgen links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	p16^INK4a overexpression predicts translational active human papillomavirus infection in tonsillar cancer International Journal of Cancer ·Markus Hoffmann, A.S. Ihloff, Tibor Görögh, Jan Bernd Weise, Asita Fazel, Matthias Krams, Werner Rittgen, Elisabeth Schwarz, Tomas Kahn	2010	110
2	Environmental influences on the production of pre-implantation embryos Theriogenology ·Ann-Kathrin Diercks, Anna Schwab, Werner Rittgen, Andreas Kruspel, Edgar Heuss, Johannes Schenkel	2010	10
3	B-RAF and N-RAS Mutations Are Preserved during Short Time In Vitro Propagation and Differentially Impact Prognosis PLoS ONE ·Selma Ugurel, Ranjit K. Thirumaran, Sandra Bloethner, Andreas Gast, Antje Sucker, Jan Mueller-Berghaus, Werner Rittgen, Kari Hemminki, Jürgen C. Becker, Rajiv Kumar, Dirk Schadendorf	2007	103
4	BioShuttle-mediated Plasmid Transfer International Journal of Medical Sciences ·Klaus Braun, Leonie von Brasch, Ruediger Pipkorn, Volker Ehemann, Juergen Jenne, Herbert Spring, Jürgen Debus, Bernd Didinger, Werner Rittgen, Waldemar Waldeck	2007	9
5	In vitro Drug Sensitivity Predicts Response and Survival after Individualized Sensitivity-Directed Chemotherapy in Metastatic Melanoma: A Multicenter Phase II Trial of the Dermatologic Cooperative Oncology Group Clinical Cancer Research ·Selma Ugurel, Dirk Schadendorf, Claudia Pföhler, K. Neuber, A. Thoelke, Jens Ulrich, Axel Hauschild, Konstanze Spieth, Martin Kaatz, Werner Rittgen, Stefan Delorme, Wolfgang Tilgen, Uwe Reinhold	2006	63
6	Glucocorticoid-mediated inhibition of chemotherapy in ovarian carcinomas International Journal of Oncology ·Chengwen Zhang, Alexander Marmé, Till Wenger, Paul Gutwein, Lutz Edler, Werner Rittgen, Klaus‐Michael Debatin, Peter Altevogt, Jürgen Mattern, Ingrid Herr	2006	39
7	Corticosteroids induce chemotherapy resistance in the majority of tumour cells from bone, brain, breast, cervix, melanoma and neuroblastoma International Journal of Oncology ·Chengwen Zhang, Benjamin M. Beckermann, Georgios Kallifatidis, Zheng Liu, Werner Rittgen, Lutz Edler, Peter Büchler, Klaus‐Michael Debatin, Markus W. Büchler, Helmut Friess, Ingrid Herr	2006	73
8	Corticosteriod-induced chemotherapy resistance in urological cancers Cancer Biology & Therapy ·C Zhang, J Mattern, Axel Haferkamp, Jesco Pfitzenmaier, Markus Hohenfellner, Werner Rittgen, Lutz Edler, Klaus‐Michael Debatin, E Groene, Ingrid Herr	2006	37
9	Detection of human papillomavirus DNA in benign and malignant sinonasal neoplasms Cancer Letters ·Michael M. Hoffmann, Nathan Klose, Stefan Gottschlich, Tibor Görögh, Abdolreza Fazel, Claudia Lohrey, Werner Rittgen, Petra Ambrosch, Edward M. Schwarz, Teri A. Kahn	2005	63
10	Tumor type M2 pyruvate kinase (TuM2‐PK) as a novel plasma tumor marker in melanoma International Journal of Cancer ·Selma Ugurel, Nellie Bell, Antje Sucker, A Zimpfer, Werner Rittgen, Dirk Schadendorf	2005	51
11	Lack of clinical efficacy of imatinib in metastatic melanoma British Journal of Cancer ·Selma Ugurel, Ralf Hildenbrand, A Zimpfer, Paul La Rosée, Peter Paschka, Antje Sucker, Petra Keikavoussi, Jürgen C. Becker, Werner Rittgen, Andreas Hochhaus, Dirk Schadendorf	2005	180
12	Cytotoxicity determination without photochemical artifacts Cancer Letters ·Michael Heuser, Marijana Kopun, Werner Rittgen, C. Granzow	2004	12
13	Cellular Predictive Factors of Drug Resistance in Non-Small Cell Lung Carcinomas Lung Cancer ·M Volm, Reet Koomägi, Werner Rittgen	2003	3
14	Single nucleotide polymorphism—disease relationships: statistical issues for the performance of association studies Mutation research. Fundamental and molecular mechanisms of mutagenesis ·Nikolaus Becker, Alexandra Nieters, Werner Rittgen	2003	12
15	In vitro evaluation of bendamustine induced apoptosis in B-chronic lymphocytic leukemia Leukemia ·Carsten Schwänen, Thomas K. Hecker, Gabriele Hübinger, Manuela Wölfle, Werner Rittgen, Lothar Bergmann, T. Karakas	2002	55
16	Primary staging and follow-up in melanoma patients – monocenter evaluation of methods, costs and patient survival British Journal of Cancer ·U. Hofmann, M Szedlak, Werner Rittgen, E. G. Jung, Dirk Schadendorf	2002	113
17	Altered DNA repair capacity and bleomycin sensitivity as risk markers for non-small cell lung cancer International Journal of Cancer ·Nahid Rajaee‐Behbahani, Peter Schmezer, Angela Risch, Werner Rittgen, Klaus Kayser, Hendrik Dienemann, Volker Schulz, P. Drings, S. Thiel, Helmut Bartsch	2001	81
18	SMR Analysis of Historical Follow‐Up Studies with Missing Death Certificates Biometrics ·Werner Rittgen, Nikolaus Becker	2000	38
19	Clinical implications of cyclins, cyclin-dependent kinases, RB and E2F1 in squamous-cell lung carcinoma International Journal of Cancer ·M Volm, Reet Koomägi, Werner Rittgen	1998	23
20	Prognostic implications of cyclins (D1, E, A), cyclin-dependent kinases (CDK2, CDK4) and tumor-suppressor genes (pRb, p16INK4A) in childhood acute lymphoblastic leukemia International Journal of Cancer ·M Volm, Reet Koomägi, Gert Stammler, Werner Rittgen, Felix Zintl, Axel Sauerbrey	1997	38

About Werner Rittgen

Werner Rittgen is a scholar working on Otorhinolaryngology, Oncology, Statistics and Probability, Cancer Research and Hematology, having authored 38 papers that have together received 2.0k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (5 papers), Cutaneous Melanoma Detection and Management (4 papers), Head and Neck Cancer Studies (4 papers), Melanoma and MAPK Pathways (3 papers), Cancer-related Molecular Pathways (3 papers), Statistical Methods and Bayesian Inference (3 papers), Lung Cancer Treatments and Mutations (3 papers) and Acute Myeloid Leukemia Research (2 papers). The work is most often cited by research in Otorhinolaryngology (219 citations), Oncology (1.0k citations), Immunology (458 citations), Cancer Research (260 citations) and Molecular Biology (843 citations). Werner Rittgen has collaborated with scholars based in Germany, United States and Sweden. Frequent co-authors include Dirk Schadendorf, M Volm, P. Drings, Antje Sucker, Selma Ugurel, Jürgen C. Becker, Lutz Edler, Petra Keikavoussi, Tibor Görögh and Nikolaus Becker. Their work appears in journals such as International Journal of Cancer, Cancer Letters, British Journal of Cancer, Mathematical Biosciences and International Journal of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact